MedTrace Logo

a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4

NCT00130858 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2009-04-02

No results posted yet for this study

Summary

Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

Conditions

  • Sarcoma, Soft Tissue

Interventions

DRUG

Topotecan

DRUG

Carboplatin

Sponsors & Collaborators

  • Deutsche Krebshilfe e.V., Bonn (Germany)

    collaborator OTHER

  • Cooperative Weichteilsarkom Study Group

    lead OTHER

Principal Investigators

  • Thomas Klingebiel, Prof. Dr. · Klinikum der Johann Wolfgang Goethe-Universität

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-12-31
Completion
2009-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00130858 on ClinicalTrials.gov